These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20962211)

  • 1. An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles.
    Velasquez LS; Hjelm BE; Arntzen CJ; Herbst-Kralovetz MM
    Clin Vaccine Immunol; 2010 Dec; 17(12):1850-8. PubMed ID: 20962211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines.
    Hjelm BE; Kilbourne J; Herbst-Kralovetz MM
    Hum Vaccin Immunother; 2014; 10(2):410-6. PubMed ID: 24280723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses.
    Guerrero RA; Ball JM; Krater SS; Pacheco SE; Clements JD; Estes MK
    J Virol; 2001 Oct; 75(20):9713-22. PubMed ID: 11559804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
    Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
    Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norwalk virus-like particles as vaccines.
    Herbst-Kralovetz M; Mason HS; Chen Q
    Expert Rev Vaccines; 2010 Mar; 9(3):299-307. PubMed ID: 20218858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
    McKay PF; King DF; Mann JF; Barinaga G; Carter D; Shattock RJ
    PLoS One; 2016; 11(2):e0148984. PubMed ID: 26862758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.
    Velasquez LS; Shira S; Berta AN; Kilbourne J; Medi BM; Tizard I; Ni Y; Arntzen CJ; Herbst-Kralovetz MM
    Vaccine; 2011 Jul; 29(32):5221-31. PubMed ID: 21640778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine.
    Jackson EM; Herbst-Kralovetz MM
    PLoS One; 2012; 7(7):e41529. PubMed ID: 22855691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang Z; Meng S; Shen S
    Mol Immunol; 2015 Dec; 68(2 Pt A):367-72. PubMed ID: 26375574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice.
    Ball JM; Hardy ME; Atmar RL; Conner ME; Estes MK
    J Virol; 1998 Feb; 72(2):1345-53. PubMed ID: 9445035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    J Immunol Res; 2018; 2018():3487095. PubMed ID: 29682589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
    Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
    Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles.
    Santi L; Batchelor L; Huang Z; Hjelm B; Kilbourne J; Arntzen CJ; Chen Q; Mason HS
    Vaccine; 2008 Mar; 26(15):1846-54. PubMed ID: 18325641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and Cellular Immune Responses to Norwalk Virus.
    Ramani S; Neill FH; Opekun AR; Gilger MA; Graham DY; Estes MK; Atmar RL
    J Infect Dis; 2015 Aug; 212(3):397-405. PubMed ID: 25635121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation.
    Springer MJ; Ni Y; Finger-Baker I; Ball JP; Hahn J; DiMarco AV; Kobs D; Horne B; Talton JD; Cobb RR
    Vaccine; 2016 Mar; 34(12):1452-8. PubMed ID: 26873053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.
    Ramirez K; Wahid R; Richardson C; Bargatze RF; El-Kamary SS; Sztein MB; Pasetti MF
    Clin Immunol; 2012 Aug; 144(2):98-108. PubMed ID: 22710446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
    Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modular virus-like particles for sublingual vaccination against group A streptococcus.
    Seth A; Kong IG; Lee SH; Yang JY; Lee YS; Kim Y; Wibowo N; Middelberg AP; Lua LH; Kweon MN
    Vaccine; 2016 Dec; 34(51):6472-6480. PubMed ID: 27866769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.